HOME - Companies - News
 
 
11 May 2023

3M enters agreements with Pierrel for sale of assets in its dental local anesthetic business portfolio


3M announced on May 2 that it has entered into agreements to sell certain assets associated with its dental local anesthetic portfolio, based in Germany, to Pierrel S.p.A., a global provider of services for the pharmaceutical industry, for a purchase price of $70 million. The move is subject to closing and other adjustments, according to a news release.

3M's local anesthetic products, sold primarily in Europe and Asia, include products sold under the Ubistesin, Xylestesin and Mepivastesin brands with related syringe and needle products and are part of the dental materials business in 3M's Oral Care Solutions Division.

As part of ongoing strategic portfolio management, 3M has decided to prioritize investments that leverage its Health Care business' core Oral Care technologies.

"We believe that these products will be well positioned with Pierrel," said Karim Mansour, president, 3M Oral Care Solutions Division, in the news release. "3M will continue to invest in oral care solutions for our Europe and Asia customers and those around the world."

These local anesthetic products had annual sales in 2022 of approximately $30 million and the impact of ongoing operations were not material to 3M's financial results.

The transaction, which is subject to information or consultation requirements with relevant works councils and other closing conditions, is expected to be completed in the third quarter of 2023. 3M expects to record a gain upon this business's divestiture which it will reflect as an adjustment in arriving at results, adjusted for special items. After the transaction closes, 3M will provide transition support to Pierrel to help facilitate a smooth transition for customers.

3M will retain ownership of its Seefeld facility and operations, which support 3M's Oral Care business.

About 3M

3M believes science helps create a brighter world for everyone. By unlocking the power of people, ideas and science to reimagine what's possible, our global team uniquely addresses the opportunities and challenges of our customers, communities, and planet. Learn how we're working to improve lives and make what's next at 3M.com/news or on Twitter at @3M or @3MNews.

Related articles

Henry Schein Dental confirms its presence at the British Dental Industry Association’s (BDIA) Dental Showcase, that will take place in London from 13 to 14 March 2026. Henry Schein’s stand number...


The expanded offering aims to support more practices adopting digital workflows, with validated materials designed for models, surgical guides, nightguards,...


SprintRay Acquires EnvisionTEC Dental Product Portfolio

SprintRay has announced the acquisition of the EnvisionTEC/ETEC(formerly part of Desktop Health) portfolio of dental products, including its patents, trademarks, inventory, and other intellectual...


Align Technology, Inc., a leading global medical device company that designs, manufactures, and sells the Invisalign System of clear aligners, iTero intraoral scanners, and exocad CAD/CAM software...


Microcopy offers a wide variety of dental products highlighted by a strong portfolio of diamond and carbide polishers, and the company plans to launch a new polisher May 1.


Read more

For 40 years, our editorial team has had the privilege of identifying and showcasing the products, technologies, materials, and solutions making a real impact across the dental pro


DS World Las Vegas is just around the corner—September 24 to September 26 at the MGM Grand


(6699.HK) (“Angel”) http://www.angelaligner.com said recently that it will appeal the August 10 first-instance judgment by the Jinan Intermediate People’s Court (Jinan City, China)


From collaborative research to exceptional patient care and education , 2025 was a year of innovation and impact at the University of Colorado Anschutz School of Dental Medicine.


 
 
 
 

 
 
 
 

Most popular

 
 

Events